Insiders Moderna, Inc. Berne S.E.

Equities

0QF

US60770K1079

Delayed Berne S.E. Other stock markets 09:30:00 15/04/2024 pm IST			5-day change	1st Jan Change
96.41 ^CHF	+1.01%		-39.82%	-47.70%

15/07	Moderna Insider Sold Shares Worth $1,756,177, According to a Recent SEC Filing	MT
12/07	China approves CSPC Pharma's RSV vaccine for clinical trials	RE

Insiders

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Moderna Insider Sold Shares Worth $1,756,177, According to a Recent SEC Filing	15/07	MT
Carisma Therapeutics Announces Nomination of First In Vivo CAR-M Development Candidate for Hepatocellular Carcinoma Under Collaboration with Moderna	28/06	CI
Moderna Insider Sold Shares Worth $30,087,339, According to a Recent SEC Filing	12/06	MT
Moderna Insider Sold Shares Worth $2,901,585, According to a Recent SEC Filing	03/06	MT
Moderna Insider Sold Shares Worth $1,909,863, According to a Recent SEC Filing	20/05	MT
Moderna Insider Sold Shares Worth $1,912,350, According to a Recent SEC Filing	18/05	MT
Moderna Insider Sold Shares Worth $1,825,220, According to a Recent SEC Filing	13/05	MT
Novavax Surges on $1.2 Billion Sanofi Vaccine Deal	11/05	MT
Moderna Insider Sold Shares Worth $1,663,855, According to a Recent SEC Filing	06/05	MT
China's drugmakers can't sell mRNA shots but haven't quit yet	19/04	RE
Moderna Insider Sold Shares Worth $1,575,300, According to a Recent SEC Filing	17/04	MT
Moderna CEO: 'Excited' About Future Following 4Q Revenue	22/02	MT
Moderna Insider Sold Shares Worth $936,981, According to a Recent SEC Filing	17/02	MT
Moderna Insider Sold Shares Worth $2,342,098, According to a Recent SEC Filing	17/02	MT
Lonza chairman to step down, drugmaker confirms targets, shares soar	26/01	RE
Moderna Insider Sold Shares Worth $1,558,500, According to a Recent SEC Filing	18/01	MT
Stéphane Bancel, CEO of Moderna: Restoring confidence in the vaccines sector	17/01	MT
Moderna Insider Sold Shares Worth $4,500,450, According to a Recent SEC Filing	28/12	MT
Stéphane Bancel, CEO of Moderna: Merck-Moderna vaccine reduces risk of skin cancer recurrence	14/12	MT
Moderna CEO Stephane Bancel to Assume Responsibility for Sales, Marketing in 2024 Amid Preparations for Product Launches	12/12	MT